EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cross-Linked Thiolated Hydroxypropil-β-Cyclodextrin for Pulmonary Drug Delivery

Luca Cerri iD, Chiara Migone, Lucia Vizzoni iD, Brunella Grassiri iD, Angela Fabiano iD, Anna Maria Piras iD, Ylenia Zambito iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25179394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Luca Cerri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy. Hauptthemen laut MEDLINE: 2-Hydroxypropyl-beta-cyclodextrin, Dexamethasone, Drug Delivery Systems. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regione Toscana, European Union cofinancing-NextGeneration EU within the Italian PNRR, Missione 4 Componente 2-Investimento 1.5-Progetto THE, Spoke 4, Regione Toscana, Ministero della Università e della Ricerca della Repubblica Italiana.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhalable formulations with cyclodextrins (CDs) as solubility and absorption enhancers show promise for pulmonary delivery. Thiolated hydroxypropyl-β-cyclodextrin (HP-β-CD-SH) has mucoadhesive properties, enhancing drug absorption. Moreover, it has self-aggregation capability, which could further improve absorption and drug stability, as well as reduce irritation. This study aims to stabilize CD nanoaggregates using bifunctional cross-linkers and evaluate their benefits for lung drug delivery compared to pristine HP-β-CD-SH.

Methods

The effectiveness of cross-linked HP-β-CD-SH nanoparticles (HP-β-CD-SH-NP) was compared to transient nanoaggregates in enhancing the activity of dexamethasone (DMS) and olive leaf extracts (OLE). DMS, a poorly soluble drug commonly used in lung treatments, and OLE, known for its antioxidant properties, were chosen. Drug-loaded HP-β-CD-SH-NP were prepared and nebulized onto a lung epithelial Air–Liquid Interface (ALI) model, assessing drug permeation and activity.

Results

HP-β-CD-SH with 25% thiolation was synthesized via microwave reaction, forming 150 nm nanoaggregates and stabilized 400 nm HP-β-CD-SH-NP. All carriers showed good complexing ability with DMS and OLE and were biocompatible in the lung ALI model. HP-β-CD-SH promoted DMS absorption, while stabilized HP-β-CD-SH-NP protected against oxidative stress.

Conclusion

HP-β-CD-SH is promising for lung delivery, especially as stabilized nanoaggregates, offering versatile administration for labile molecules like natural extracts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

2-Hydroxypropyl-beta-cyclodextrinDexamethasoneDrug Delivery SystemsAnimalsHumansSulfhydryl CompoundsLungNanoparticlesAdministration, InhalationDrug Carriersbeta-CyclodextrinsRats

Stichwörter der Autor:innen

cyclodextrinsdrug deliverylung deliverymucoadhesionnanocarriernatural extract

Substanzen

2-Hydroxypropyl-beta-cyclodextrinDexamethasoneSulfhydryl CompoundsDrug Carriersbeta-Cyclodextrins

Autor:innen und Institutionen

  • Department of Pharmacy, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy.
  • Department of Life Sciences, University of Siena, 53100 Siena, Italy.
  • Center for Instrument Sharing of the University of Pisa (CISUP), University of Pisa, 56126 Pisa, Italy.
  • Research Centre for Nutraceutical and Healthy Foods "NUTRAFOOD", University of Pisa, 56126 Pisa, Italy.

ORCID-Profile: Luca Cerri, Lucia Vizzoni, Brunella Grassiri, Angela Fabiano, Anna Maria Piras, Ylenia Zambito

Förderung

  • Regione Toscana
  • European Union cofinancing-NextGeneration EU within the Italian PNRR, Missione 4 Componente 2-Investimento 1.5-Progetto THE, Spoke 4
  • Regione Toscana, Ministero della Università e della Ricerca della Repubblica Italiana
  • European Union cofinancing—NextGeneration EU within the Italian Piano Nazionale di Ripresa e Resilienza, Missione 4 Componente 2—Investimento 1.5—Creazione e r…
  • Spoke n. 4 “Nanotechnologies for diagnosis and therapy”

Zitieren

APA

Cerri, L., Migone, C., Vizzoni, L., Grassiri, B., Fabiano, A., Piras, A. M., & Zambito, Y. (2024). Cross-Linked Thiolated Hydroxypropil-β-Cyclodextrin for Pulmonary Drug Delivery. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179394

Vancouver

Cerri L, Migone C, Vizzoni L, Grassiri B, Fabiano A, Piras AM, et al. Cross-Linked Thiolated Hydroxypropil-β-Cyclodextrin for Pulmonary Drug Delivery. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179394

BibTeX
@article{Cerri2024,
  author = {Cerri, Luca and Migone, Chiara and Vizzoni, Lucia and Grassiri, Brunella and Fabiano, Angela and Piras, Anna Maria and Zambito, Ylenia},
  title = {Cross-Linked Thiolated Hydroxypropil-β-Cyclodextrin for Pulmonary Drug Delivery},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25179394}
}
Kostenlos starten →